Product Information
Proprietary IngredientGREEN biotechnology
Greenyn develops proprietary ingredients to fulfill unmet need
-
Insumate® bitter melon extract contains the patented amino peptide sequence mcIRBP-19, which is a scientific-recognized active compound for glucose modulation. The clinical efficacy of Insumate® has been validated by two officially clinical studies. It is easy to be absorbed by human body due to the low molecular weight of mcIRBP-19. The underlying mechanism of glucose modulation has been verified by in-vitro and animal models. Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
-
Antromax® (NDIN No. 1170) is the world’s first and safe Antrodia cinnamomea product acknowledged by the U.S. Food and Drug Administration (USFDA).
-
Zymologist®101 Phyto Fermented Drink is produced by our proprietary technology TotalFerm™, which facilitates the complete release of phytochemicals, such as flavonoids (polyphenols), carotenoids, organic sulfides, and phenolic acids, from fruits and vegetables. Zymologist® contains less than 2.5% (w/v) sugar, high dietary fiber, and abundant antioxidants, and it is suitable for every population to acquire multiple health benefits.
One-stop service
ONE-STOP SERVICEGREENYN biotechnology
Professional OEM/ODM Service
Enterprise Performance
OUR PerformanceGREENYN biotechnology
We have serviced over thousands of international clients and earned their trust
-
Exclusive branded ingredients
120items01 -
Greenyn proprietary ingredients
05products02 -
Ingredients
500items03 -
Dosage forms
09types04 -
Accumulation of customized products
6823products05 -
Global clients
2378companies06 -
Customized products each year
660items07
Media center
LATEST NEWSGREEN biotechnology
-
Latest News222022 Sep
Welcome to SupplySide WEST 2022
We sincerely invite you to attend SupplySide WEST 2022. In this show, we will exhibit our innovative and proprietary ingredients. -
Market Information042022 Jan
糖友必知飲食觀念 吃對苦瓜胜肽更加分!
從大量苦瓜中取出的高親和力活性的蛋白質成份,稱為「專利定序19肽」,也稱為「mclRBP-19」,不需要刺激胰島素,即可促進血糖代謝,比起一般苦瓜胜肽產品更直接有效。 -
Latest News072021 Dec
好事成雙!綠茵生技榮獲2021傑出生技產業獎及正式公開發行
綠茵生技捷報連連,榮獲台灣生物產業發展協會舉辦的『2021 Taiwan BIO Awards傑出生技產業獎』之「潛力標竿獎」,營運及創新研發能力深獲肯定,在穩健踏實的成長下,公開發行亦已於7月21日生效,邁入新的里程碑。 -
Market Information012021 Dec
食品資訊雜誌304期:植物胰島素-專利定序19肽介紹
現代人因為生活作息不正常,高油高鹽,崇尚精緻飲食的習慣,加上忙碌、壓力大、吃多、少動,導致現代人文明病「代謝症候群」找上門。代謝症候群有血脂、血糖異常及腹部肥胖(中央性肥胖)等問題,而胰島素阻抗是造成代謝症候群的主要原因,如長期血糖調控不佳,就容易導致糖尿病甚至是其他慢性疾病發生。據統計台灣糖尿病病友已突破230萬人,而台灣地區的代謝症候群盛行率,更是高達20%,隨著年齡上升有增加趨勢。在廣大的需求趨動下,苦瓜胜肽順勢而生,也造就了市場上的熱銷。 -
Market Information012021 Dec
食品資訊雜誌303期:台灣牛樟芝犇向國際-牛樟芝永續發展及多元研究
美國食品藥品監督管理局(FDA)甫回覆一台灣業者之牛樟芝菌絲體於新膳食補充成份(New Dietary Ingredients, NDI)安全性評議 “無保留意見”,讓產官學界對於台灣國寶接軌國際添加信心。日前舉辦的「台灣牛樟芝產業國際發展與臨床應用研討會」,共數十位專家學者與會,會中報告牛樟芝護肝、解酒、排毒等功能驗證,及牛樟芝菌絲體於B型肝炎患者臨床應用的高度安全性,透過堅實的研究及國際安全性驗證,可望帶動國內牛樟芝產業並搶進美國百億美元的草本類膳食補充劑市場。 -
Latest News182021 Nov
蔡總統親臨頒獎 綠茵生技榮獲第30屆「國家磐石獎」
綠茵生技榮獲第30屆「國家磐石獎」殊榮,日前假台北君悅酒店舉行頒獎典禮,由蔡英文總統親臨頒獎祝賀,並嘉勉得獎企業不僅代表中小企業最高榮耀,也身負中小企業卓越典範的使命。 -
Latest News082021 Nov
綠茵生技榮獲2021傑出生技產業獎之「潛力標竿獎」
綠茵生技榮獲「2021 Taiwan BIO Awards傑出生技產業獎」之「潛力標竿獎」,於11月4日「BIO Asia-Taiwan 2021亞洲生技大展實體展」中,由前副總統陳建仁院士授獎,代表綠茵生技在研發能量及未來發展的潛力、促進台灣生技產業升級及經濟發展的貢獻獲得高度肯定。 -
Latest News032021 Nov
甫獲美國FDA認可之綠茵生技 將於生技展呈現國際化全方位服務
綠茵生技已於今年7月正式公開發行,今年將偕同子公司-康普森生技,以綠茵集團之姿一同參與亞洲美容保養暨生技保健展。